Category: Diagnostic Technologies

Diagnostic Technologies

AI Prostate Cancer Test Enters Clinical Use in Puerto Rico

The test analyzes digital biopsy images to help predict treatment response and long-term outcomes for patients with localized prostate cancer.

Diagnostic Technologies

Pictor Holdings Secures $7.5 Million to Expand Protein Analysis Platform

The funding will support manufacturing and commercial partnerships for a system that analyzes multiple protein targets in less than two hours.

Diagnostic Technologies

Experts Call for End to Routine ‘Corrected’ Calcium Reporting

A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.

Anatomic Pathology

New Imaging Technology Could Speed Up Cancer Diagnosis

Early results indicate the process could reduce sample preparation time by approximately 40% to 50%, while improving consistency by removing variability linked to staining conditions.

Digital Pathology

Tecan and NVIDIA Integrate New Artificial Intelligence Capabilities into Lab Analytics Platform

Tecan has integrated agentic AI, powered by NVIDIA’s BioNeMo Agent Toolkit, into its Introspect laboratory analytics platform to enable proactive operations and improve productivity in clinical labs.

Clinical Chemistry

Testosterone Therapy Frequently Prescribed Without Recommended Diagnostic Workup

Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.

Flow Cytometry

Watchmaker Genomics Launches Tools to Streamline Sequencing Workflows

The new technologies address library normalization and amplification accuracy for high-throughput and oncology sequencing.

Hematology & Serology

New Study Links Biomarker Elevations to Kidney Transplant Failure Risk

Elevated donor-derived cell-free DNA levels are linked to higher kidney transplant failure risk, suggesting earlier detection of allograft injury before loss of kidney function.

Immunoassay

Seegene Launches New Test for Multidrug-Resistant Organisms in Europe

The assay is CE marked under the European Union In Vitro Diagnostic Regulation and identifies resistance genes to help prevent hospital-acquired infections.

Mass Spectrometry

University of Florida Researchers Develop Rapid Urine Test for Prostate Cancer

The noninvasive method uses paper spray and mass spectrometry to identify disease biomarkers in less than 30 seconds.

Microbiology

Study to Evaluate One-Hour Testing for Drug-Resistant Infections

The Fleming Initiative and Cepheid have launched a 30-month study in England to compare rapid molecular and traditional culture screening for drug-resistant carbapenemase-producing Enterobacterales in hospital settings.

Molecular Diagnostics

Countable Labs and Promega Partner for Sample Preparation and Rare Variant Detection

The agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.

Point-of-Care

Roche Receives FDA Clearance for Point-of-Care Bordetella Test

The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.

Urinalysis & Toxicology

Urine Metabolite Test Shows Potential for Autism Risk Screening

The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.